13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001517796
Total reported value
$109.5M
$109.5M
117 檔
26.0%
In Q4 2025, Rangeley Capital, LLC's U.S. equity holdings reached a combined market value of $109.5M, distributed across 117 disclosed stock positions.
Rangeley Capital, LLC executed strategic sector rebalancing during Q4 2025, establishing 46 new positions while fully exiting 53 holdings and trimming 28 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | WBD | Warner Bros Discovery Inc | Stock-Comm Services | 6.57% | -1.54% | — | |
| 2 | GDEN | Golden Entertainment Inc | Stock-Other | 4.74% | — | — | |
| 3 | CLMT | Calumet Inc | Stock-Other | 4.28% | -1.22% | -21.66% | |
| 4 | PRTA | Prothena Corporation plc | Stock-Other | 4.16% | -0.51% | -6.40% | |
| 5 | YEXT | Yext Inc | Stock-Other | 3.92% | +0.19% | +7.41% | |
| 6 | ARVN | Arvinas Inc | Stock-Other | 3.90% | -0.98% | -43.08% | |
| 7 | ABUS | Arbutus Biopharma CORP | Stock-Other | 3.36% | — | — | |
| 8 | RNAGBP | Avidity Biosciences Inc | Stock-Other | 3.23% | — | — | |
| 9 | RPTX | Repare Therapeutics Inc | Stock-Other | 2.78% | — | +99.39% | |
| 10 | ✓ | Stock-Other | 2.75% | -1.02% | EXIT | ||
| 11 | SEG | Seaport Entertainment Group | Stock-Other | 2.52% | +0.53% | -0.31% | |
| 12 | DK | Delek US Holdings Inc | Stock-Other | 2.51% | -1.38% | -50.49% | |
| 13 | ✓ | Berto Acquisition CORP | Stock-Other | 2.44% | +0.11% | NEW | |
| 14 | GRND | Grindr Inc | Stock-Other | 2.38% | +0.14% | — | |
| 15 | PLYM | Plymouth Industrial Reit Inc | Stock-Other | 2.19% | — | — | |
| 16 | ECHO | Echostar Corp-a | Stock-Comm Services | 2.17% | -0.36% | +4.35% | |
| 17 | FWRD | Forward Air CORP | Stock-Other | 2.04% | -0.78% | +106.95% | |
| 18 | FLL | Full House Resorts Inc | Stock-Other | 1.94% | +0.36% | +0.56% | |
| 19 | KROS | Keros Therapeutics Inc | Stock-Other | 1.64% | -0.05% | -62.57% | |
| 20 | CWAN | Clearwater Analytics Holdings, Inc. | Stock-Tech | 1.60% | -0.64% | EXIT | |
| 21 | BHF | Brighthouse Financial Inc | Stock-Financials | 1.58% | — | +21.33% | |
| 22 | SEPN | Septerna Inc | Stock-Other | 1.52% | -0.71% | -25.23% | |
| 23 | NLOP | Net Lease Office Property | Stock-Other | 1.47% | -0.32% | -2.17% | |
| 24 | MRSN | Mersana Therapeutics Inc | Stock-Other | 1.37% | — | — | |
| 25 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 1.36% | — | — | |
| 26 | STHO | Star Holdings | Stock-Other | 1.28% | +0.69% | +5.71% | |
| 27 | LEG | Leggett & Platt Inc | Stock-Consumer Disc | 1.24% | -2.04% | EXIT | |
| 28 | CORZW | Core Scientific Inc - 27 | Stock-Other | 1.17% | +0.27% | -29.22% | |
| 29 | CDZI | Cadiz Inc | Stock-Other | 1.16% | -0.05% | -51.74% | |
| 30 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 1.02% | — | -75.00% | |
| 31 | SEM | Select Medical Holdings CORP | Stock-Other | 1.00% | -0.79% | EXIT | |
| 32 | OMEX | Odyssey Marine Exploration | Stock-Other | 0.99% | — | +26.96% | |
| 33 | RGR | Sturm Ruger & Co Inc | Stock-Other | 0.95% | — | — | |
| 34 | SWKH | Swk Holdings CORP | Stock-Other | 0.90% | -1.04% | EXIT | |
| 35 | KURA | Kura Oncology Inc | Stock-Other | 0.89% | +0.14% | -14.25% | |
| 36 | GLUE | Monte Rosa Therapeutics Inc | Stock-Other | 0.88% | -0.43% | EXIT | |
| 37 | TGNA | Tegna Inc | Stock-Other | 0.85% | — | +430.00% | |
| 38 | BCYC | Bicycle Therapeutics Plc-adr | Stock-Other | 0.78% | -0.07% | +1.54% | |
| 39 | ZIM | ZIM Integrated Shipping Services Ltd. | Stock-Other | 0.72% | -0.17% | — | |
| 40 | PL | Planet Labs Pbc | Stock-Industrials | 0.66% | — | — | |
| 41 | LNSR | Lensar Inc | Stock-Other | 0.57% | -0.36% | EXIT | |
| 42 | HGV | Hilton Grand Vacations Inc | Stock-Other | 0.56% | -0.95% | EXIT | |
| 43 | ✓ | Stock-Other | 0.52% | -0.02% | -25.72% | ||
| 44 | ✓ | Stock-Other | 0.46% | — | — | ||
| 45 | EM | Smart Share Global LTD - Adr | Stock-Other | 0.46% | -0.34% | EXIT | |
| 46 | KORE | Kore Group Holdings Inc | Stock-Other | 0.46% | — | — | |
| 47 | 2KZ0 | Kezar Life Sciences Inc | Stock-Other | 0.45% | -1.75% | EXIT | |
| 48 | ABVX | Abivax Sa-adr | Stock-Other | 0.45% | +1.15% | -33.33% | |
| 49 | BUR | Burford Capital Limited | Stock-Other | 0.43% | -0.05% | EXIT | |
| 50 | ✓ | General Purp Acquisition Cor | Stock-Other | 0.42% | -0.03% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RPTX | Repare Therapeutics Inc | +1.8% | +99.39% | Add |
| 2 | FWRD | Forward Air CORP | +1% | +106.95% | Add |
| 3 | TGNA | Tegna Inc | +0.7% | +430.00% | Add |
| 4 | ECHO | Echostar Corp-a | +0.7% | +4.35% | Add |
| 5 | BHF | Brighthouse Financial Inc | +0.5% | +21.33% | Add |
| 6 | SWKH | Swk Holdings CORP | +0.4% | +53.66% | Add |
| 7 | OMEX | Odyssey Marine Exploration | +0.2% | +26.96% | Add |
| 8 | GLUE | Monte Rosa Therapeutics Inc | +0.2% | -40.27% | Trim |
| 9 | TMQ | Trilogy Metals Inc | +0.2% | — | Unchanged |
| 10 | PLRX | Pliant Therapeutics Inc | +0.2% | +273.63% | Add |
| 11 | BBIO | Bridgebio Pharma Inc | +0.1% | — | Unchanged |
| 12 | SEPN | Septerna Inc | +0.1% | -25.23% | Trim |
| 13 | ABUS | Arbutus Biopharma CORP | +0.1% | — | Unchanged |
| 14 | ✓ | D. Boral Arc Acq I CORP. | +0.1% | +26.09% | Add |
| 15 | AVIR | Atea Pharmaceuticals Inc | 0% | — | Unchanged |
| 16 | VYNE | Vyne Therapeutics Inc | 0% | +100.00% | Add |
| 17 | WW | Ww International Inc-new | 0% | +9.09% | Add |
| 18 | STHO | Star Holdings | 0% | +5.71% | Add |
| 19 | HGV | Hilton Grand Vacations Inc | 0% | — | Unchanged |
| 20 | PEPG | Pepgen Inc | 0% | -17.73% | Trim |
| 21 | ✓ | Fifth Era Acquisition CORP I | 0% | +7.96% | Add |
| 22 | ABVX | Abivax Sa-adr | 0% | -33.33% | Trim |
| 23 | ✓ | Otg Acquisition CORP. I | 0% | +10.08% | Add |
| 24 | ✓ | Oaktree Acquisition CORP Iii | 0% | +5.83% | Add |
| 25 | ✓ | Cslm Digita Asset Acq CORP I | 0% | +10.56% | Add |
| 26 | ✓ | 0% | +12.10% | Add | |
| 27 | IMXI | International Money Express | 0% | — | Unchanged |
| 28 | ✓ | — | -0.05% | Trim | |
| 29 | MGNX | Macrogenics Inc | — | — | Unchanged |
| 30 | ANEB | Anebulo Pharmaceuticals Inc | — | +150.00% | Add |
| 31 | ANTX | An2 Therapeutics Inc | 0% | — | Unchanged |
| 32 | ✓ | 0% | — | Unchanged | |
| 33 | PMVP | Pmv Pharmaceuticals Inc | 0% | — | Unchanged |
| 34 | SEER | Seer Inc | 0% | — | Unchanged |
| 35 | IMA | Imagenebio Inc | 0% | +21.63% | Add |
| 36 | ✓ | 0% | +0.94% | Add | |
| 37 | ✓ | Highview Merger CORP | 0% | — | Unchanged |
| 38 | ✓ | Rallybio CORP | 0% | -51.81% | Trim |
| 39 | OKUR | Onkure Therapeutics Inc-a | 0% | -6.75% | Trim |
| 40 | LNSR | Lensar Inc | 0% | +7.27% | Add |
| 41 | ✓ | 0% | — | Unchanged | |
| 42 | ✓ | Roman Dbdr Acquisition CORP | 0% | — | Unchanged |
| 43 | ✓ | 0% | -0.07% | Trim | |
| 44 | KURA | Kura Oncology Inc | 0% | -14.25% | Trim |
| 45 | ✓ | Spark I Acquisition CORP | 0% | -23.71% | Trim |
| 46 | SITC | Site Centers CORP | 0% | — | Unchanged |
| 47 | CORZ | Core Scientific Inc | 0% | — | Unchanged |
| 48 | HEPS | D-market Electronic Serv-adr | -0.1% | — | Unchanged |
| 49 | AIFC | Ai Financial CORP | -0.1% | -39.96% | Trim |
| 50 | FDMT | 4d Molecular Therapeutics In | -0.1% | -9.38% | Trim |
According to official SEC Form 13F filings, Rangeley Capital, LLC reported a total U.S. public equity portfolio value of $109.5M across 117 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including WBD, GDEN, CLMT) accounted for 26.0% of total reported equity market value during Q4 2025.
Top New Position Initiated
WBD
市值: $7.9M
Top Position Liquidated / Trimmed
WOW
前期市值: $4.9M
During Q4 2025, Rangeley Capital, LLC's top holdings by market value included WBD (6.6%)、GDEN (4.7%)、CLMT (4.3%). The largest single position, WBD, represented 6.6% of total portfolio value.
In Q4 2025, Rangeley Capital, LLC made 152 total portfolio adjustments, initiating 46 new buys, adding to 25 positions, trimming 28 holdings, and fully liquidating 53 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.